Status
Conditions
Treatments
About
This study aims to present our center's experience in managing postoperative tricuspid valve regurgitation over the past 25years and to analyze the outcomes of these surgical treatments.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria:patients who underwent surgical treatment from 1999 to 2023 for tricuspid valve disease following cardiac surgery
Exclusion Criteria: age <16,severe tricuspid regurgitation secondary to primary pulmonary hypertension, and those with substantial missing case data.
375 participants in 2 patient groups
Loading...
Central trial contact
Yingjie Ke; Huanlei Huang
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal